VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy

Author： Greenberg Joshua I   Cheresh David A  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.9, Iss.11, 2009-11, pp. : 1347-1356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VEGF blocking therapy in the treatment of cancer

By Glade-Bender Julia   Kandel Jessica J   Yamashiro Darrell J  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 263-276

Informa Healthcare

Access to resources Recommend Favorite

Tumor-specific allogeneic cells for cancer therapy

By Marcus Assaf   Eshhar Zelig  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 12, 2011-12 ,pp. : 1551-1554

Informa Healthcare

Access to resources Recommend Favorite

Emerging Roles of Calreticulin in Cancer: Implications for Therapy

By  

Current Protein and Peptide Science, Vol. 19, Iss. 4, 2018-02 ,pp. : 344-357

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells

By Wang Da-Guang   Sun Ya-Bin   Ye Fei   Li Wei   Kharbuja Punyaram   Gao Ling   Zhang David   Suo Jian  

Molecular and Cellular Biochemistry, Vol. 386, Iss. 1-2, 2014-01 ,pp. : 143-152

Springer Publishing Company

Access to resources Recommend Favorite

Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA

By Gorges Tobias M.   Schiller Johanna   Schmitz Arndt   Schuetzmann Daniel   Schatz Christoph   Zollner Thomas M.   Krahn Thomas   von Ahsen Oliver  

Biomarkers, Vol. 17, Iss. 6, 2012-09 ,pp. : 498-506

Informa Healthcare

Access to resources Recommend Favorite